CB 2009
Alternative Names: CB-2009Latest Information Update: 28 May 2024
At a glance
- Originator Unknown
- Developer CORTIBON
- Class Antidepressants; Anxiolytics; Behavioural disorder therapies; Sleep disorder therapies
- Mechanism of Action Corticotropin releasing factor receptor 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Anxiety disorders; Depressive disorders; Sleep disorders
Most Recent Events
- 28 May 2024 No recent reports of development identified for preclinical development in Anxiety-disorders in Germany
- 28 May 2024 No recent reports of development identified for preclinical development in Depressive disorders in Germany
- 28 May 2024 No recent reports of development identified for preclinical development in Sleep-disorders in Germany